Clinical and economic burden of severe asthma among US patients treated with biologic therapies
Clinical and economic burden of severe asthma among US patients treated with biologic therapies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clinical and economic burden of severe asthma among US patients treated with biologic therapies have?
Clinical and economic burden of severe asthma among US patients treated with biologic therapies has 45 citations in the OpenAlex counts ScholarIQ stores.
When was Clinical and economic burden of severe asthma among US patients treated with biologic therapies published?
Clinical and economic burden of severe asthma among US patients treated with biologic therapies has 2021 year in the ScholarIQ index.
What is the open-access status of Clinical and economic burden of severe asthma among US patients treated with biologic therapies?
Clinical and economic burden of severe asthma among US patients treated with biologic therapies has hybrid oa status in the ScholarIQ index.
What is the DOI of Clinical and economic burden of severe asthma among US patients treated with biologic therapies?
The DOI for Clinical and economic burden of severe asthma among US patients treated with biologic therapies is on the source record.
What is the PMID of Clinical and economic burden of severe asthma among US patients treated with biologic therapies?
The PMID for Clinical and economic burden of severe asthma among US patients treated with biologic therapies is on the source record.
What is the OpenAlex record for Clinical and economic burden of severe asthma among US patients treated with biologic therapies?
The OpenAlex for Clinical and economic burden of severe asthma among US patients treated with biologic therapies is on the source record.